Search
Alnylam Pharmaceuticals Inc
ALNYAdd to Watchlist
205.420USD
-81.200-28.33%
Close 07-29 16:00（ET）Quotes delayed by 15 min
27.19BMarket Cap
50.28P/E TTM
Alnylam Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-07-29The current valuation score of Alnylam Pharmaceuticals Inc is 6.93, ranking 141 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 70.15, which is 1977.63% below the recent high of 1457.49 and 829.40% above the recent low of -511.69.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.